Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Validation of the Critical-Care Pain Observation Tool (CPOT) in the Greek Population

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03654443
Recruitment Status : Suspended (The study is currently suspended due to the COVID19 crisis)
First Posted : August 31, 2018
Last Update Posted : March 31, 2020
Sponsor:
Information provided by (Responsible Party):
Georgia Micha, Saint Savvas Anticancer Hospital

Brief Summary:
The aim of this study is to validate the Critical-Care Pain Observation Tool (CPOT) in the setting of the Intensive care unit (ICU). Prior to patient recruitment the tool will be translated by the method of translation-back translation by Greek and English native speakers. The tool will be administered to patients who are admitted into the ICU.

Condition or disease Intervention/treatment Phase
Pain Intensive Care Units Diagnostic Test: Critical care pain observation tool Not Applicable

Detailed Description:
The aim of this study is to validate the Critical-Care Pain Observation Tool (CPOT) in the setting of the Intensive care unit (ICU). Prior to patient recruitment the tool will be translated by the method of translation-back translation by Greek and English native speakers. The study is designed as a prospective randomized crossover clinical trial. Patients will be randomly allocated into two study groups. In Group I the CPOT tool is administered prior to a painful stimulus (ITime0), during the painful stimulus (ITime1) and soon afterwards (ITime2).In Group II the CPOT tool is administered prior to a non painful stimulus(IITime0), during a non-painful stimulus (IITime1) and soon afterwards (IITime2). After these trials the patients in the two groups will crossover into the other group and the whole process will be repeated. The painful stimulus is set to be the passive turning of the patient into the bed and the non painful stimulus is the cleaning of the arm or leg. 20 minutes afterwards the CPOT tool is administered once again in both groups in order to obtain the values when there is no stimulus (ITime3). The tool is administered by two trained members of the study team in a blind manner. Both of the observers administer the tool at the same time but one of them is positioned in the ward of the patient and the other one behind a curtain with no contact with the observer but only with the patient and the monitor.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 74 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Masking Description: Only the two observers are aware of the study group and none of the rest of the study team
Primary Purpose: Other
Official Title: Greek Validation of the Critical-Care Pain Observation Tool (CPOT) in the Intensive Care Unit Setting
Actual Study Start Date : July 1, 2018
Estimated Primary Completion Date : October 1, 2020
Estimated Study Completion Date : January 1, 2021

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Critical Care

Arm Intervention/treatment
Experimental: Group Painful stimulus
The CPOT tool is administered in a crossover manner in Group one prior to a painful stimulus (IT0), during the painful stimulus (IT1) and soon afterwards (IT2)
Diagnostic Test: Critical care pain observation tool
The CPOT tool is administered in a crossover manner by two study observers

Experimental: Group Non-painful stimulus
The CPOT tool is administered in a crossover manner in Group one prior to a non-painful stimulus (IIT0), during the painful stimulus (IIT1) and soon afterwards (IIT2)
Diagnostic Test: Critical care pain observation tool
The CPOT tool is administered in a crossover manner by two study observers




Primary Outcome Measures :
  1. Greek validation of the CPOT tool (Critical Care Pain Observation Tool) in the ICU patients [ Time Frame: The CPOT tool (Critical Care Pain Observation Tool) is administered 1 minute prior to a painful stimulus (ITime0) which is set to be the patient's bed repositioning ]
    Validation of the Greek version of the CPOT tool (Critical Care Pain Observation Tool) for assessing the pain in the intensive care unit patients.Maximum score 8 points.For those patients with a CPOT score of ≤ 2:There is likely minimal to no pain present.For those patients with a CPOT score of >2:There is a medium to severe level of pain.

  2. Greek validation of the CPOT tool (Critical Care Pain Observation Tool) in the ICU patients [ Time Frame: The CPOT tool(Critical Care Pain Observation Tool) is administered 10 seconds after a painful stimulus (ITime1) which is set to be the patient's bed repositioning ]
    Validation of the Greek version of the CPOT tool (Critical Care Pain Observation Tool) for assessing the pain in the intensive care unit patients.Maximum score 8 points.For those patients with a CPOT score of ≤ 2:There is likely minimal to no pain present.For those patients with a CPOT score of >2:There is a medium to severe level of pain.

  3. Greek validation of the CPOT tool (Critical Care Pain Observation Tool) in the ICU patients [ Time Frame: The CPOT tool(Critical Care Pain Observation Tool) is administered 1 minute after a painful stimulus (ITime2) which is set to be the patient's bed repositioning ]
    Validation of the Greek version of the CPOT tool (Critical Care Pain Observation Tool) for assessing the pain in the intensive care unit patients.Maximum score 8 points.For those patients with a CPOT score of ≤ 2:There is likely minimal to no pain present.For those patients with a CPOT score of >2:There is a medium to severe level of pain.

  4. Greek validation of the CPOT tool (Critical Care Pain Observation Tool) in the ICU patients [ Time Frame: The CPOT tool (Critical Care Pain Observation Tool)is administered 20 minutes after a painful stimulus (ITime3) which is set to be the patient's bed repositioning ]
    Validation of the Greek version of the CPOT tool (Critical Care Pain Observation Tool) for assessing the pain in the intensive care unit patients.Maximum score 8 points.For those patients with a CPOT score of ≤ 2:There is likely minimal to no pain present.For those patients with a CPOT score of >2:There is a medium to severe level of pain.

  5. Greek validation of the CPOT tool (Critical Care Pain Observation Tool) in the ICU patients [ Time Frame: The CPOT tool (Critical Care Pain Observation Tool)is administered 1 minute prior to a non painful stimulus (IITime0) which is set to be the patient's blood pressure measurement ]
    Validation of the Greek version of the CPOT tool (Critical Care Pain Observation Tool) for assessing the pain in the intensive care unit patients.Maximum score 8 points.For those patients with a CPOT score of ≤ 2:There is likely minimal to no pain present.For those patients with a CPOT score of >2:There is a medium to severe level of pain.

  6. Greek validation of the CPOT tool (Critical Care Pain Observation Tool) in the ICU patients [ Time Frame: The CPOT tool(Critical Care Pain Observation Tool) is administered 10 seconds after a non painful stimulus (IITime1) which is set to be the patient's blood pressure measurement ]
    Validation of the Greek version of the CPOT tool (Critical Care Pain Observation Tool) for assessing the pain in the intensive care unit patients.Maximum score 8 points.For those patients with a CPOT score of ≤ 2:There is likely minimal to no pain present.For those patients with a CPOT score of >2:There is a medium to severe level of pain.

  7. Greek validation of the CPOT tool (Critical Care Pain Observation Tool) in the ICU patients [ Time Frame: The CPOT tool (Critical Care Pain Observation Tool)is administered 1 minute after a painful stimulus (IITime2) which is set to be the patient's blood pressure measurement ]
    Validation of the Greek version of the CPOT tool (Critical Care Pain Observation Tool) for assessing the pain in the intensive care unit patients.Maximum score 8 points.For those patients with a CPOT score of ≤ 2:There is likely minimal to no pain present.For those patients with a CPOT score of >2:There is a medium to severe level of pain.


Secondary Outcome Measures :
  1. Correlation of physiological parameters to CPOT tool (Critical Care Pain Observation Tool) values [ Time Frame: The recordings will be performed 1 minute before, 10 seconds after, 1 minute after and 20 minutes after a painful and a non painful stimulus ]
    Physiological parameters as mean arterial blood pressure (MAP in mmHg) will be recorded in all patients. In order to calculate the mean arterial pressure, systolic and diastolic pressures will be recorded in the time periods of the assessment.

  2. Correlation of numeric pain rating scale (NPRS) to CPOT tool (Critical Care Pain Observation Tool)values [ Time Frame: The recordings will be performed 1 minute before, 10 seconds after, 1 minute after and 20 minutes after a painful and a non painful stimulus ]
    NPRS scale (0 equals no pain and 10 equals maximum pain possible)will be performed in all patients that are able to communicate in order to correlate the results with those of the CPOT tool

  3. Correlation of physiological parameters to CPOT tool(Critical Care Pain Observation Tool) values [ Time Frame: The recordings will be performed 1 minute before, 10 seconds after, 1 minute after and 20 minutes after a painful and a non painful stimulus ]
    Physiological parameters as heart rate will be recorded in all patients.

  4. Correlation of physiological parameters to CPOT tool (Critical Care Pain Observation Tool)values [ Time Frame: The recordings will be performed 1 minute before, 10 seconds after, 1 minute after and 20 minutes after a painful and a non painful stimulus ]
    Physiological parameters as respiratory rate will be recorded in all patients



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients admitted in the ICU
  • Age> 18 years old
  • No hearing or visual deficit
  • No contraindication to body repositioning

Exclusion Criteria:

  • Patients with neurological deficit
  • Patients administered with neuromuscular blocking agents
  • Patients with motor or sensory deficits

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03654443


Locations
Layout table for location information
Greece
Saint Savvas Anticancer Hospital of Athens
Athens, Greece
Sponsors and Collaborators
Saint Savvas Anticancer Hospital
Investigators
Layout table for investigator information
Principal Investigator: Georgia Micha, MD, MSc, PhD Saint Savvas Anticancer Hospital of Athens
Publications:
Layout table for additonal information
Responsible Party: Georgia Micha, Principal Investigator, Anaesthesiologist, MD, MSc, PhD, Saint Savvas Anticancer Hospital
ClinicalTrials.gov Identifier: NCT03654443    
Other Study ID Numbers: StSavvasAH
First Posted: August 31, 2018    Key Record Dates
Last Update Posted: March 31, 2020
Last Verified: March 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Pain
Neurologic Manifestations